FDA

Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats
Investors Business Daily
Mon, 08/26/24 - 11:11 am
Galapagos
CAR-T
FDA
non-Hodgkin lymphoma
Gilead Sciences
Novartis
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds
Fierce Pharma
Fri, 08/23/24 - 10:55 am
FDA
stomach cancer
Bristol Myers Squibb
Opdivo
Yervoy
Merck
Keytruda
BeiGene
Tevimbra
Updated COVID shots from Pfizer, Moderna cleared by FDA
BioPharma Dive
Thu, 08/22/24 - 10:03 pm
COVID-19
vaccines
Pfizer
Moderna Therapeutics
FDA
Gilead’s Livdelzi (Seladelpar) for Primary Biliary Cholangitis Promises Pruritus Reduction
Xtalks
Thu, 08/22/24 - 10:00 pm
FDA
Livdelzi
Gilead Sciences
primary biliary cholangitis
A First for Hypoparathyroidism — Yorvipath (Palopegteriparatide) Earns FDA Nod
Xtalks
Thu, 08/22/24 - 09:51 pm
Yorvipath
FDA
hypoparathyroidism
Ascendis Pharma
Updated COVID vaccines are coming soon
NPR
Thu, 08/22/24 - 11:20 am
FDA
COVID-19
vaccines
First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1
Biopharma Reporter
Thu, 08/22/24 - 11:15 am
ImmPACT Bio
CAR-T
MS
multiple sclerosis
FDA
clinical trials
BMS eyes April FDA verdict on Opdivo/Yervoy in liver cancer
Pharmaphorum
Thu, 08/22/24 - 11:09 am
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
FDA
FDA’s plan to expand device surveillance faces challenges, GAO finds
Medtech Dive
Wed, 08/21/24 - 10:30 pm
FDA
regulatory
GAO
medtehc
devices
Pharma’s concerns pile up months after Supreme Court’s landmark Chevron decision
Pharma Voice
Wed, 08/21/24 - 11:18 am
Supreme Court
Chevron Doctrine
FDA
CMS
Inflation Reduction Act
Lawmakers urge FDA to investigate clinical trials run in tandem with China's military
Fierce Pharma
Tue, 08/20/24 - 10:06 pm
FDA
China
clinical trials
Biosecure Act
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Regeneron
FDA
linvoseltamab
Multiple Myeloma
Targeting AZ's Tagrisso, Johnson & Johnson's Rybrevant combo wins key FDA nod in first-line lung cancer
Fierce Pharma
Tue, 08/20/24 - 11:36 am
JNJ
AstraZeneca
FDA
non-small cell lung cancer
Rybrevant
Lazcluze
Tagrisso
BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings
Pharma Voice
Mon, 08/19/24 - 09:58 am
Bristol Myers Squibb
KarXT
FDA
schizophrenia
AbbVie
Liquida Misses Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity
BioSpace
Mon, 08/19/24 - 09:57 am
Liquida
Yutrepia
pulmonary hypertension
FDA
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Motley Fool
Sun, 08/18/24 - 09:19 pm
Eli Lilly
FDA
obesity
Zepbound
Lykos co-founder Doblin to step down after MDMA setback
Pharmaphorum
Fri, 08/16/24 - 11:14 am
Lykos Therapeutics
Rick Doblin
MDMA
FDA
FDA approves AstraZeneca's non-small cell lung cancer treatment
Reuters
Thu, 08/15/24 - 10:06 pm
AstraZeneca
Imfinzi
FDA
non-small cell lung cancer
The FDA calls them ‘recalls,’ yet the targeted medical devices often remain in use
Medical Marketing and Media
Thu, 08/15/24 - 11:47 am
device recalls
Medtech
FDA
FDA clears use of Cresilon's gel to stop severe bleeding in seconds
Reuters
Thu, 08/15/24 - 11:42 am
Cresilon
FDA
bleeding control
Traumagel

Pages